Population pharmacokinetics and pharmacodynamics of the neutralizing antibodies bamlanivimab and etesevimab in patients with mild to moderate COVID‐19 infection
2007 ◽
Vol 63
(5)
◽
pp. 548-561
◽
1998 ◽
Vol 38
(3)
◽
pp. 227-235
◽
2012 ◽
Vol 91
(3)
◽
pp. 497-505
◽
2005 ◽
Vol 56
(2)
◽
pp. 388-395
◽
Population pharmacokinetics and pharmacodynamics of dobutamine in neonates on the first days of life
2020 ◽
Vol 86
(2)
◽
pp. 318-328
◽